Cargando…
Comparison of standard dose with high dose of methylprednisolone in the management of COVID-19 patients admitted in ICU
CONTEXT: The pathological progression in severe Coronavirus Disease 2019 (COVID-19) includes an excessive and unregulated pro-inflammatory cytokine storm. Though the efficacy of corticosteroids like methylprednisolone (MPS) in severe COVID-19 is proven now, its dose and duration are not precise. AIM...
Autores principales: | Singhai, Abhishek, Bhagtana, Parneet Kaur, Pawar, Neeraj, Pavan, G. Sai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797098/ https://www.ncbi.nlm.nih.gov/pubmed/35136768 http://dx.doi.org/10.4103/jfmpc.jfmpc_908_21 |
Ejemplares similares
-
Clinical profile and spectrum of bacteriuria in patients with diabetes: An analytical study
por: Biswas, Diwashish, et al.
Publicado: (2022) -
Clinical Characteristics and Outcome of Hospitalized COVID-19 Patients Treated with Standard Dose of Dexamethasone or High Dose of Methylprednisolone
por: Russo, Alessandro, et al.
Publicado: (2022) -
Retrospective comparison of convalescent plasma with continuing high‐dose methylprednisolone treatment in SARS patients
por: Soo, Y. O. Y., et al.
Publicado: (2004) -
Obstructive sleep apnea is highly prevalent in COVID19 related moderate to severe ARDS survivors: findings of level I polysomnography in a tertiary care hospital
por: Goyal, Abhishek, et al.
Publicado: (2022) -
A comparison of three dose timings of methylprednisolone in infant cardiopulmonary bypass
por: Withington, Davinia E, et al.
Publicado: (2014)